CredoScientia - Bibliothèque

Multidisciplinary approaches in the management of advanced hepatocellular carcinoma: Exploring future directions.

Recently, we read the article "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature"…

Thérapies de Conversion

Liu, X. J., Lin, Y. X., Chen, L. X., Yang, W. J., & Hu, B. (2024). Multidisciplinary approaches in the management of advanced hepatocellular carcinoma: Exploring future directions.. World J Gastrointest Oncol, 16(10), 4052-4054. https://doi.org/10.4251/wjgo.v16.i10.4052

15/10/2024 Lire →

Conversion therapy in advanced perihilar cholangiocarcinoma based on patient-derived organoids: A case report.

BACKGROUND: Patient-derived organoids (PDOs) have been demonstrated to predict the response to drugs in multiple cancer types. However, it remains unclear about its application in cholangiocarcinoma.C…

Thérapies de Conversion

He, Y. G., Zhang, L. Y., Li, J., Wang, Z., Zhao, C. Y., Zheng, L., & Huang, X. B. (2024). Conversion therapy in advanced perihilar cholangiocarcinoma based on patient-derived organoids: A case report.. World J Gastrointest Oncol, 16(10), 4274-4280. https://doi.org/10.4251/wjgo.v16.i10.4274

15/10/2024 Lire →

Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges.

Recently, the published an article entitled "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of …

Thérapies de Conversion

He, Y. F. (2024). Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges.. World J Gastrointest Oncol, 16(10), 4289-4297. https://doi.org/10.4251/wjgo.v16.i10.4289

15/10/2024 Lire →

Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages.

This manuscript is based on a case reported by Song published in the . Several challenges remain in the field of hepatocellular carcinoma (HCC) conversion therapy. Consequently, only a limited number…

Thérapies de Conversion

Giorgio, A., & De, L. u. c. a. . M. (2024). Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages.. World J Clin Cases, 12(28), 6241-6243. https://doi.org/10.12998/wjcc.v12.i28.6241

06/10/2024 Lire →

Intermediate hepatocellular carcinoma: new horizons and prospects for our patients.

INTRODUCTION: In recent years, significant progress has been made in treatment strategies for intermediate-stage hepatocellular carcinoma (HCC), which is a highly heterogeneous patient population requ…

Thérapies de Conversion

Lo, P. r. i. n. z. i. . F., Rossari, F., Silletta, M., Foti, S., Camera, S., Vitiello, F., Amadeo, E., De, C. o. b. e. l. l. i. . F., Aldrighetti, L., Rimini, M., & Casadei-Gardini, A. (2024). Intermediate hepatocellular carcinoma: new horizons and prospects for our patients.. Expert Rev Gastroenterol Hepatol, 18(10), 661-672. https://doi.org/10.1080/17474124.2024.2422367

01/10/2024 Lire →

Comparing watch-and-wait vs. resection in radiologic complete response after conversion therapy for unresectable hepatocellular carcinoma: correspondence.

Thérapies de Conversion

Luo, L., Liu, Y., & Zhu, L. (2024). Comparing watch-and-wait vs. resection in radiologic complete response after conversion therapy for unresectable hepatocellular carcinoma: correspondence.. Ann Med Surg (Lond), 86(10), 6350-6351. https://doi.org/10.1097/MS9.0000000000002489

01/10/2024 Lire →

Reply to: "Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed".

Thérapies de Conversion

Zeng, Z. X., Wu, J. Y., Zhuang, S. W., & Yan, M. L. (2024). Reply to: "Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed".. Hepatol Int, 18(5), 1589-1590. https://doi.org/10.1007/s12072-024-10682-6

01/10/2024 Lire →

Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery.

INTRODUCTION: Transarterial chemoembolization combined with lenvatinib and PD-1 inhibitor (triple therapy) has displayed encouraging clinical outcomes for unresectable hepatocellular carcinoma (uHCC).…

Thérapies de Conversion

Zeng, Z. X., Wu, J. Y., Wu, J. Y., Zhang, Z. B., Wang, K., Zhuang, S. W., Li, B., Zhou, J. Y., Lin, Z. T., Li, S. Q., Li, Y. N., Fu, Y. K., & Yan, M. L. (2024). Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery.. Liver Cancer, 13(5), 498-508. https://doi.org/10.1159/000536376

01/10/2024 Lire →

[Arterial prophylactic occlusion technique in the application of surgery for locally advanced pancreatic cancer with arterial involvement after conversion therapy].

To investigate and compare the clinical outcomes of the arterial pre-occlusion technique(APOT) and the traditional technique in the surgery of locally advanced pancreatic cancer with arterial involve…

Thérapies de Conversion

Zheng, K. L., Liu, X. Y., Shi, X. H., Wang, H., Yin, X. Y., Wu, X. Q., Gu, L. Y., Li, P. H., Li, Y. K., Jing, W., Guo, S. W., Song, B., Gao, S. Z., & Jin, G. (2024). [Arterial prophylactic occlusion technique in the application of surgery for locally advanced pancreatic cancer with arterial involvement after conversion therapy].. Zhonghua Wai Ke Za Zhi, 62(10), 938-946. https://doi.org/10.3760/cma.j.cn112139-20240415-00185

01/10/2024 Lire →

Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo‑immunotherapy: A case report.

The combination of chemotherapy and immunotherapy for metastatic cholangiocarcinoma (CCA) offers promising improvements in survival and response rates beyond traditional treatments. TOPAZ-1 and KEYNOT…

Thérapies de Conversion

Orlandi, E., Toscani, I., Trubini, S., Schena, A., Palladino, M. A., Anselmi, E., Vecchia, S., Romboli, A., & Giuffrida, M. (2024). Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo‑immunotherapy: A case report.. Oncol Lett, 28(4), 473. https://doi.org/10.3892/ol.2024.14606

01/10/2024 Lire →

Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study.

PURPOSE: The prognosis of patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT) is extremely poor, and systemic therapy is currently the mainstream treatment. This study a…

Thérapies de Conversion

Ou, X., Wu, J., Wu, J., Fu, Y., Zeng, Z., Li, S., Li, Y., Liu, D., Li, H., Li, B., Zhou, J., Zhuang, S., Cheng, S., Zhang, Z., Wang, K., Qu, S., & Yan, M. (2024). Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study.. Cancer Res Treat, 56(4), 1207-1218. https://doi.org/10.4143/crt.2023.1165

01/10/2024 Lire →

Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report.

BACKGROUND: Surgical resection and liver transplantation (LT) are the most effective curative options for hepatocellular carcinoma (HCC). However, few patients with huge HCC (> 10 cm in diameter), esp…

Thérapies de Conversion

Liang, L. C., Huang, W. S., Guo, Z. X., You, H. J., Guo, Y. J., Cai, M. Y., Lin, L. T., Wang, G. Y., & Zhu, K. S. (2024). Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report.. World J Gastroenterol, 30(36), 4071-4077. https://doi.org/10.3748/wjg.v30.i36.4071

28/09/2024 Lire →